Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach.
Front Cell Dev Biol
; 10: 879057, 2022.
Article
in En
| MEDLINE
| ID: mdl-35757005
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Risk_factors_studies
Language:
En
Journal:
Front Cell Dev Biol
Year:
2022
Type:
Article
Affiliation country:
Belgium